Cargando…

Integrative Analysis of Metabolomics and Transcriptomics Data Identifies Prognostic Biomarkers Associated With Oral Squamous Cell Carcinoma

BACKGROUND: Oral squamous cell carcinoma (OSCC) is the most malignant neoplasm in oral cancer. There is growing evidence that its progression involves altered metabolism. The current method of evaluating prognosis is very limited, and metabolomics may provide a new approach for quantitative evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Lihua, Chen, Zhuo, Chen, Lihuang, Kang, Jian, Shi, Yingying, Liu, Liwei, Zhang, Shuhua, Jia, Qingquan, Huang, Yi, Sun, Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529182/ https://www.ncbi.nlm.nih.gov/pubmed/34692531 http://dx.doi.org/10.3389/fonc.2021.750794

Ejemplares similares

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus
por: Li, Xibo, et al.
Publicado: (2022)

Metabolomics and Transcriptomics Analysis on Metabolic Characteristics of Oral Lichen Planus
por: Xin, Ming-zhe, et al.
Publicado: (2021)

Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma
por: Huang, Guang-zhao, et al.
Publicado: (2019)

Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma
por: Ishikawa, Shigeo, et al.
Publicado: (2022)

PSGL-1 is a novel tumor microenvironment prognostic biomarker with cervical high-grade squamous lesions and more
por: Lin, Yingying, et al.
Publicado: (2023)

Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma
por: Hu, Xiaoshan, et al.
Publicado: (2022)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2021)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
por: Wang, Shuqin, et al.
Publicado: (2022)

Integrated Non-targeted and Targeted Metabolomics Uncovers Amino Acid Markers of Oral Squamous Cell Carcinoma
por: Yang, Xi-Hu, et al.
Publicado: (2020)

Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics
por: Zhou, Huihui, et al.
Publicado: (2019)

Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients
por: Li, Hainan, et al.
Publicado: (2021)

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022)

Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer
por: Liu, Bo, et al.
Publicado: (2022)

Identification of Biomarkers Associated with Cancerous Change in Oral Leukoplakia Based on Integrated Transcriptome Analysis
por: Li, Chunshen, et al.
Publicado: (2022)

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022)

Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma
por: Chen, Zhongjian, et al.
Publicado: (2020)

Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges
por: Almangush, Alhadi, et al.
Publicado: (2021)

Diagnostic Value of CircRNAs as Potential Biomarkers in Oral Squamous Cell Carcinoma: a Meta-Analysis
por: Wang, Mingfei, et al.
Publicado: (2021)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma
por: Pan, Xue, et al.
Publicado: (2023)

Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment
por: Zeng, Qingquan, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2020)

Prognostic Value of an Immune-Related Gene Signature in Oral Squamous Cell Carcinoma
por: Zhu, Chao, et al.
Publicado: (2021)

Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022)

Identifying α-KG-dependent prognostic signature for lower-grade glioma based on transcriptome profiles
por: Zhang, Tan, et al.
Publicado: (2022)

A Novel Prognostic Model for Oral Squamous Cell Carcinoma: The Functions and Prognostic Values of RNA-Binding Proteins
por: Lu, Yingjuan, et al.
Publicado: (2021)

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
por: Lin, Zuyuan, et al.
Publicado: (2023)

Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction
por: Lao, Yueqiong, et al.
Publicado: (2022)

Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data
por: Giulietti, Matteo, et al.
Publicado: (2018)

Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma
por: Wongpattaraworakul, Wattawan, et al.
Publicado: (2022)

The prognostic role of sex and hemoglobin levels in patients with oral tongue squamous cell carcinoma
por: Tagliabue, Marta, et al.
Publicado: (2022)

The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma
por: Ding, Meng, et al.
Publicado: (2021)

Integrative Multi−Omics Analysis Reveals Candidate Biomarkers for Oral Squamous Cell Carcinoma
por: Wan, Zhengqing, et al.
Publicado: (2022)

CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint
por: Ding, Zhuang, et al.
Publicado: (2021)

Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
por: Zhuo, Shenghua, et al.
Publicado: (2023)

Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio
por: Mattavelli, Davide, et al.
Publicado: (2019)

The clinical implications of circulating microRNAs as potential biomarkers in screening oral squamous cell carcinoma
por: Gao, Huan, et al.
Publicado: (2022)

Development of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma
por: Hsueh, Pei-Chun, et al.
Publicado: (2022)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
por: He, Kang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a4dbhb4goe49vn9hu9dmsvdoos